Skip to search.
 BSE Up 0.19% NSE Up 0.28%
Streaming
Ticker Tape: On

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS

20.66 Up 0.50(2.48%) 18 May 1:30AM|After Hours : 20.66 0.00 (0.00%) 18 May 2:02AM

Add to Portfolio
Prev Close:20.16
Open:20.30
Bid:16.56 x 100
Ask:25.00 x 400
1y Target Est:16.83
Beta:1.69
Next Earnings Date: 7-Aug-13ISIS Earnings announcement
Day's Range:20.07 - 20.75
52wk Range:7.56 - 23.03
Volume:1,729,851
Avg Vol (3m):1,618,800
Market Cap:2.14B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISUp 2.48%2.14B
NVO 0.00%93.15B
TEVAUp 0.68%34.28B
AGNUp 0.99%30.06B
FRXDown 0.44%10.26B
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.12
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.76
Quarterly EPS Est (Jun-13) :-0.23
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.88

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product, KYNAMRO injection, is an apo-B synthesis inhibitor for patients with homozygous famili... View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback